Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel, et al.
Science (2020) Vol. 371, Iss. 6529, pp. 602-609
Closed Access | Times Cited: 1148

Showing 1-25 of 1148 citing articles:

Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Cancer Discovery (2022) Vol. 12, Iss. 1, pp. 31-46
Open Access | Times Cited: 3350
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1093
The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 895
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 879
Toward personalized treatment approaches for non-small-cell lung cancer
Meina Wang, Roy S. Herbst, Chris Boshoff
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1345-1356
Closed Access | Times Cited: 710
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1632-1640
Open Access | Times Cited: 591
Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 477
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 315-324
Open Access | Times Cited: 414
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam, Romina E. Araya, April Huang, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5338-5356.e21
Open Access | Times Cited: 377
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 373
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 333
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 704-712
Open Access | Times Cited: 326
Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 325
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 324
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A. McCulloch, Diwakar Davar, Richard R. Rodrigues, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 545-556
Open Access | Times Cited: 299
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 298
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 285
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 280
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease
Magdalena K. Stoeva, Jeewon Garcia-So, Nicholas J. Justice, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 277
Metastatic colorectal cancer: mechanisms and emerging therapeutics
Alice E. Shin, Filippo G. Giancotti, Anil K. Rustgi
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 4, pp. 222-236
Open Access | Times Cited: 276
Resistance Mechanisms to Anti-PD Cancer Immunotherapy
Matthew D. Vesely, Tianxiang Zhang, Lieping Chen
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 45-74
Closed Access | Times Cited: 272
Next-generation sequencing: insights to advance clinical investigations of the microbiome
Caroline R. Wensel, Jennifer L. Pluznick, Steven L. Salzberg, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 7
Open Access | Times Cited: 269
Immunotherapy in colorectal cancer: current achievements and future perspective
Ahui Fan, Boda Wang, Xin Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3837-3849
Open Access | Times Cited: 262
The person-to-person transmission landscape of the gut and oral microbiomes
Mireia Valles‐Colomer, Aitor Blanco‐Míguez, Paolo Manghi, et al.
Nature (2023) Vol. 614, Iss. 7946, pp. 125-135
Open Access | Times Cited: 258
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
Joseph Tintelnot, Yang Xu, Till Robin Lesker, et al.
Nature (2023) Vol. 615, Iss. 7950, pp. 168-174
Open Access | Times Cited: 255
Page 1 - Next Page

Scroll to top